candidate vaccine, SCB-2020S

BIOLOGICAL2 trials

Sponsors

Clover Biopharmaceuticals AUS Pty

Conditions

COVID-19

Phase 1

Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults

CompletedNCT05228314

Clover Biopharmaceuticals AUS PtyCOVID-19

Start: 2022-05-30End: 2023-04-23Updated: 2023-07-03

Phase 2

Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults

WithdrawnNCT04950751

Clover Biopharmaceuticals AUS PtyCOVID-19

Start: 2021-08-31End: 2022-04-30Updated: 2021-09-10